EU approves type 2 diabetes drug for children

The Committee for Medicinal Products for Human Use of the European Medicines Agency has approved the GLP-1 agonist, liraglutide, for the treatment of children and adolescents with type 2 diabetes.Medscape

Source: Society for Endocrinology - July 4, 2019 Category: Endocrinology Source Type: news